Literature DB >> 798697

Staphylococcus epidermidis in the circulating blood of normal and thrombocytopenic human subjects: immunological data.

G G Tedeschi, D Amici, G Sprovieri, A Vecchi.   

Abstract

Immunological studies, performed with human sera and rabbit antisera upon some strains of Staph. epidermidis carried in the circulating blood of normal and thrombocytopenic subjects, indicate that the reactivity is very low and almost completely related to antigenic properties common to Staph. aureus.

Entities:  

Mesh：

Year:  1976        PMID： 798697     DOI： 10.1007/bf01924475

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  2 in total

1.  L- and conventional forms of micrococci in the circulating blood of thrombocytopenic patients.

Authors:  G G Tedeschi; D Amici; I Santarelli
Journal:  Experientia       Date:  1975-09-15

2.  Unstable L-forms of micrococci in human foetal blood.

Authors:  G G Tedeschi; D Amici; I Santarelli
Journal:  Experientia       Date:  1976
  2 in total
  4 in total

1.  Presence of mycobacterial L-forms in human blood: Challenge of BCG vaccination.

Authors:  Nadya Markova; Georgi Slavchev; Lilia Michailova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Analysis of microbial sequences in plasma cell-free DNA for early-onset breast cancer patients and healthy females.

Authors:  Yu-Feng Huang; Yen-Ju Chen; Tan-Chi Fan; Nai-Chuan Chang; Yi-Jie Chen; Mohit K Midha; Tzu-Han Chen; Hsiao-Hsiang Yang; Yu-Tai Wang; Alice L Yu; Kuo-Ping Chiu
Journal:  BMC Med Genomics       Date:  2018-02-13       Impact factor: 3.063

3.  Dysbiotic microbiota in autistic children and their mothers: persistence of fungal and bacterial wall-deficient L-form variants in blood.

Authors:  N Markova
Journal:  Sci Rep       Date:  2019-09-16       Impact factor: 4.379

4.  Application of cell-free DNA sequencing in characterization of bloodborne microbes and the study of microbe-disease interactions.

Authors:  Kuo-Ping Chiu; Alice L Yu
Journal:  PeerJ       Date:  2019-08-06       Impact factor: 2.984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.